{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:46:27Z","timestamp":1790617587140,"version":"4.1.0"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1097\/cmr.0b013e32835e7713","type":"journal-article","created":{"date-parts":[[2013,1,25]],"date-time":"2013-01-25T11:52:51Z","timestamp":1359114771000},"page":"114-124","source":"Crossref","is-referenced-by-count":20,"title":["Difference of interferon-\u03b1 and interferon-\u03b2 on melanoma growth and lymph node metastasis in mice"],"prefix":"10.1097","volume":"23","author":[{"given":"Mi Ryung","family":"Roh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenlong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Sook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hei-Cheul","family":"Jeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Young","family":"Rha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kee Yang","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210129","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3322\/canjclin.52.1.23","article-title":"Cancer statistics, 2002.","volume":"52","author":"Jemal","year":"2002","journal-title":"CA Cancer J Clin"},{"key":"R2-4-20210129","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1470-2045(10)70288-6","article-title":"Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trial.","volume":"12","author":"Hansson","year":"2011","journal-title":"Lancet Oncol"},{"key":"R3-4-20210129","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1200\/JCO.2000.18.12.2444","article-title":"High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690S9111C9190.","volume":"18","author":"Kirkwood","year":"2000","journal-title":"J Clin Oncol"},{"key":"R4-4-20210129","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0305-7372(03)00074-4","article-title":"Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit A meta-analysis of the randomised trials.","volume":"29","author":"Wheatley","year":"2003","journal-title":"Cancer Treat Rev"},{"key":"R5-4-20210129","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/jnci\/djq009","article-title":"Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis.","volume":"102","author":"Mocellin","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"R6-4-20210129","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.1996.14.1.7","article-title":"Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.","volume":"14","author":"Kirkwood","year":"1996","journal-title":"J Clin Oncol"},{"key":"R7-4-20210129","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1189\/jlb.1105653","article-title":"Tumor and lymph node lymphangiogenesis - impact on cancer metastasis.","volume":"80","author":"Tobler","year":"2006","journal-title":"J Leukoc Biol"},{"key":"R8-4-20210129","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cell.2010.01.045","article-title":"Lymphangiogenesis: molecular mechanisms and future promise.","volume":"140","author":"Tammela","year":"2010","journal-title":"Cell"},{"key":"R9-4-20210129","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1172\/JCI44751","article-title":"Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse.","volume":"121","author":"Kerjaschki","year":"2011","journal-title":"J Clin Invest"},{"key":"R10-4-20210129","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0002-9440(10)65007-9","article-title":"Inhibition of angiogenesis and vascular tumor growth by interferon-producing cells: a gene therapy approach.","volume":"156","author":"Albini","year":"2000","journal-title":"Am J Pathol"},{"key":"R11-4-20210129","first-page":"872","article-title":"Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta.","volume":"59","author":"Dong","year":"1999","journal-title":"Cancer Res"},{"key":"R13-4-20210129","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/jnci\/95.6.437","article-title":"Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.","volume":"95","author":"Von Marschall","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"R14-4-20210129","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10585-008-9141-y","article-title":"Impact of sentinel lymphadenectomy on survival in a murine model of melanoma.","volume":"25","author":"Rebhun","year":"2008","journal-title":"Clin Exp Metastasis"},{"key":"R15-4-20210129","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1046\/j.1523-1747.2003.12057.x","article-title":"Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a humanized SCID mouse model.","volume":"120","author":"Kunstfeld","year":"2003","journal-title":"J Invest Dermatol"},{"key":"R16-4-20210129","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2559.2004.01898.x","article-title":"Cyclooxygenase 2 (COX2) expression is associated with poor outcome in ER-negative, but not ER-positive, breast cancer.","volume":"45","author":"Witton","year":"2004","journal-title":"Histopathology"},{"key":"R17-4-20210129","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1001\/archderm.136.3.428","article-title":"Intralesional interferon treatment of lentigo maligna.","volume":"136","author":"Cornejo","year":"2000","journal-title":"Arch Dermatol"},{"key":"R18-4-20210129","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1610-0387.2006.06054.x","article-title":"Intralesional therapy of metastatic spreading melanoma with beta-interferon.","volume":"4","author":"Rapprich","year":"2006","journal-title":"J Dtsch Dermatol Ges"},{"key":"R19-4-20210129","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.gie.2006.05.032","article-title":"Local injection of interferon beta in malignant melanoma of the esophagus as adjuvant of systemic pre- and postoperative DAV chemotherapy: case report with 7 years of long-term survival.","volume":"66","author":"Kawada","year":"2007","journal-title":"Gastrointest Endosc"},{"key":"R20-4-20210129","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00403-008-0841-6","article-title":"Interferon-beta therapy for malignant melanoma: the dose is crucial for inhibition of proliferation and induction of apoptosis of melanoma cells.","volume":"300","author":"Kubo","year":"2008","journal-title":"Arch Dermatol Res"},{"key":"R21-4-20210129","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/jjco\/hyn114","article-title":"A pilot study of human interferon beta gene therapy for patients with advanced melanoma by in vivo transduction using cationic liposomes.","volume":"38","author":"Matsumoto","year":"2008","journal-title":"Jpn J Clin Oncol"},{"key":"R22-4-20210129","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1346-8138.1995.tb03889.x","article-title":"In vitro comparative study of the antitumor effects of human interferon-alpha, beta and gamma on the growth and invasive potential of human melanoma cells.","volume":"22","author":"Horikoshi","year":"1995","journal-title":"J Dermatol"},{"key":"R23-4-20210129","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1089\/jir.2010.0054","article-title":"Gene regulatory and clinical effects of interferon beta in patients with metastatic melanoma: a phase II trial.","volume":"31","author":"Borden","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"R24-4-20210129","doi-asserted-by":"crossref","first-page":"231S","DOI":"10.1111\/1523-1747.ep12875837","article-title":"Antitumor activities of interferon alpha, beta, and gamma and their combinations on human melanoma cells in vitro: changes of proliferation, melanin synthesis, and immunophenotype.","volume":"95","author":"Garbe","year":"1990","journal-title":"J Invest Dermatol"},{"key":"R25-4-20210129","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1089\/jir.1997.17.355","article-title":"Interferon-beta induces S phase accumulation selectively in human transformed cells.","volume":"17","author":"Qin","year":"1997","journal-title":"J Interferon Cytokine Res"},{"key":"R26-4-20210129","first-page":"1821","article-title":"Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAILApo2L induction in melanoma cell lines.","volume":"7","author":"Chawla-Sarkar","year":"2001","journal-title":"Clin Cancer Res"},{"key":"R27-4-20210129","first-page":"3354","article-title":"Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.","volume":"6","author":"Hong","year":"2000","journal-title":"Clin Cancer Res"},{"key":"R28-4-20210129","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/excr.1998.4329","article-title":"Induction of multiple programmed cell death pathways by IFN-beta in human non-small-cell lung cancer cell lines.","volume":"247","author":"Zhang","year":"1999","journal-title":"Exp Cell Res"},{"key":"R29-4-20210129","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.biochem.67.1.227","article-title":"How cells respond to interferons.","volume":"67","author":"Stark","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"R31-4-20210129","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1089\/jir.1986.6.615","article-title":"Antiproliferative effects of interferons on human melanoma cells in the human tumor colony-forming assay.","volume":"6","author":"Schiller","year":"1986","journal-title":"J Interferon Res"},{"key":"R32-4-20210129","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/1523-1747.ep12480767","article-title":"Effects of interferons on cultured human melanocytes in vitro: interferon-beta but not-alpha or -gamma inhibit proliferation and all interferons significantly modulate the cell phenotype.","volume":"97","author":"Krasagakis","year":"1991","journal-title":"J Invest Dermatol"},{"key":"R33-4-20210129","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1248\/bpb1978.7.951","article-title":"Antitumor effect of human recombinant interferon-beta against human melanomas transplanted into nude mice.","volume":"7","author":"Gomi","year":"1984","journal-title":"J Pharmacobiodyn"},{"key":"R34-4-20210129","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/jnci\/84.15.1185","article-title":"Antiproliferative potencies of interferons on melanoma cell lines and xenografts: higher efficacy of interferon beta.","volume":"84","author":"Johns","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"R35-4-20210129","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor angiogenesis: therapeutic implications.","volume":"285","author":"Folkman","year":"1971","journal-title":"N Engl J Med"},{"key":"R36-4-20210129","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer.","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"R37-4-20210129","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1056\/NEJM199512283332608","article-title":"Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis.","volume":"333","author":"Folkman","year":"1995","journal-title":"N Engl J Med"},{"key":"R38-4-20210129","first-page":"105","article-title":"The clinical diagnosis of malignant melanoma.","volume":"2","author":"Mihm","year":"1975","journal-title":"Semin Oncol"},{"key":"R39-4-20210129","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1126\/science.6823562","article-title":"Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.","volume":"219","author":"Senger","year":"1983","journal-title":"Science"},{"key":"R40-4-20210129","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0006-291X(89)92678-8","article-title":"Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.","volume":"161","author":"Ferrara","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"R41-4-20210129","first-page":"329","article-title":"Differential expression of basic fibroblast growth factor (bFGF) in melanocytic lesions demonstrated by in situ hybridization. Implications for tumor progression.","volume":"144","author":"Reed","year":"1994","journal-title":"Am J Pathol"},{"key":"R42-4-20210129","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/(SICI)1096-9896(199912)189:4<546::AID-PATH487>3.0.CO;2-L","article-title":"Expression of interleukin-8 detected by in situ hybridization correlates with worse prognosis in primary cutaneous melanoma.","volume":"189","author":"Nurnberg","year":"1999","journal-title":"J Pathol"},{"key":"R43-4-20210129","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199205283262203","article-title":"Interferon alfa-2a therapy for life-threatening hemangiomas of infancy.","volume":"326","author":"Ezekowitz","year":"1992","journal-title":"N Engl J Med"},{"key":"R44-4-20210129","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1542\/peds.103.6.1145","article-title":"Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a.","volume":"103","author":"Kaban","year":"1999","journal-title":"Pediatrics"},{"key":"R45-4-20210129","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1089\/jir.2008.0118","article-title":"VEGF secretion is inhibited by interferon-alpha in several melanoma cell lines.","volume":"28","author":"Raig","year":"2008","journal-title":"J Interferon Cytokine Res"},{"key":"R46-4-20210129","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1365-2133.2002.04867.x","article-title":"Metastatic pathways and time courses in the orderly progression of cutaneous melanoma.","volume":"147","author":"Meier","year":"2002","journal-title":"Br J Dermatol"},{"key":"R47-4-20210129","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/emboj\/20.4.672","article-title":"Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis.","volume":"20","author":"Mandriota","year":"2001","journal-title":"EMBO J"},{"key":"R48-4-20210129","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/84643","article-title":"Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis.","volume":"7","author":"Skobe","year":"2001","journal-title":"Nat Med"},{"key":"R49-4-20210129","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/84635","article-title":"VEGF-D promotes the metastatic spread of tumor cells via the lymphatics.","volume":"7","author":"Stacker","year":"2001","journal-title":"Nat Med"},{"key":"R50-4-20210129","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0002-9440(10)64328-3","article-title":"Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.","volume":"162","author":"Dadras","year":"2003","journal-title":"Am J Pathol"},{"key":"R51-4-20210129","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/modpathol.3800410","article-title":"Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes.","volume":"18","author":"Dadras","year":"2005","journal-title":"Mod Pathol"},{"key":"R52-4-20210129","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/jcp.2005.028431","article-title":"Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study.","volume":"59","author":"Massi","year":"2006","journal-title":"J Clin Pathol"},{"key":"R53-4-20210129","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0002-9440(10)61765-8","article-title":"Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma.","volume":"159","author":"Skobe","year":"2001","journal-title":"Am J Pathol"},{"key":"R54-4-20210129","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc863","article-title":"Lymphangiogenesis and cancer metastasis.","volume":"2","author":"Stacker","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"R55-4-20210129","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1084\/jem.20041896","article-title":"VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis.","volume":"201","author":"Hirakawa","year":"2005","journal-title":"J Exp Med"},{"key":"R56-4-20210129","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1182\/blood-2006-05-021758","article-title":"VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites.","volume":"109","author":"Hirakawa","year":"2007","journal-title":"Blood"},{"key":"R57-4-20210129","doi-asserted-by":"crossref","first-page":"774","DOI":"10.2353\/ajpath.2007.060761","article-title":"Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis.","volume":"170","author":"Harrell","year":"2007","journal-title":"Am J Pathol"},{"key":"R58-4-20210129","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s00403-005-0633-1","article-title":"Expression pattern of the lymphatic and vascular markers VEGFR-3 and CD31 does not predict regional lymph node metastasis in cutaneous melanoma.","volume":"297","author":"Wobser","year":"2006","journal-title":"Arch Dermatol Res"},{"key":"R59-4-20210129","first-page":"7059","article-title":"Induction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma.","volume":"62","author":"Clarijs","year":"2002","journal-title":"Cancer Res"},{"key":"R60-4-20210129","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.ejca.2008.12.015","article-title":"Tumoural expression and circulating level of VEGFR-3 (Flt-4) in metastatic melanoma patients: correlation with clinical parameters and outcome.","volume":"45","author":"Mouawad","year":"2009","journal-title":"Eur J Cancer"},{"key":"R61-4-20210129","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.immuni.2010.12.016","article-title":"T lymphocytes negatively regulate lymph node lymphatic vessel formation.","volume":"34","author":"Kataru","year":"2011","journal-title":"Immunity"}],"container-title":["Melanoma Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CMR.0b013e32835e7713","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T20:24:16Z","timestamp":1621887856000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008390-201304000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/cmr.0b013e32835e7713","relation":{},"ISSN":["0960-8931"],"issn-type":[{"value":"0960-8931","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}